Order Article Reprints

Zaki WA, El-Sayed SM, Alswah M, El-Morsy A, Bayoumi AH, Mayhoub AS, Moustafa WH, Awaji AA, Roh EJ, Hassan AHE, et al. Design, Synthesis, In Vitro, and In Silico Studies of New N⁵-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors. Pharmaceuticals. 2023; 16(11):1593. https://doi.org/10.3390/ph16111593

Zaki, Waheed A., Selwan M. El-Sayed, Mohamed Alswah, Ahmed El-Morsy, Ashraf H. Bayoumi, Abrahman S. Mayhoub, Walaa H. Moustafa, Aeshah A. Awaji, Eun Joo Roh, Ahmed H.E. Hassan, and et al. 2023. "Design, Synthesis, In Vitro, and In Silico Studies of New N⁵-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors" Pharmaceuticals 16, no. 11: 1593. https://doi.org/10.3390/ph16111593

Zaki, W. A., El-Sayed, S. M., Alswah, M., El-Morsy, A., Bayoumi, A. H., Mayhoub, A. S., Moustafa, W. H., Awaji, A. A., Roh, E. J., Hassan, A. H. E., & Mahmoud, K. (2023). Design, Synthesis, In Vitro, and In Silico Studies of New N⁵-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors. Pharmaceuticals, 16(11), 1593. https://doi.org/10.3390/ph16111593